Skip to main content
SpringerLink
Log in

Reviewing the clinical utility of ventricular assist device log files

  • Review Article
  • Published:
Indian Journal of Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Background

Ventricular assist devices (VADs) have provided a temporising solution to many individuals with refractory heart failure (HF) while awaiting a suitable donor for heart transplantation which remains the gold standard in treatment. Many of the discussions around VADs involve ongoing morbidity; however, one aspect of VADs that is often overlooked is the utility of their log files. We decided to review the literature for mentions of the clinical utility of VAD log files.

Methods

A keyword search was utilised on PUBMED using the terms ‘Ventricular Assist Device’ and ‘Log files’. Perhaps unsurprisingly, this search only yielded 4 results with further articles being discovered through the bibliography of these publications.

Results

The 4 identified articles provided basic information on log files, particularly with reference to the HVAD. Logs can be categorised into three types—data (pump parameters), events (changes in parameters) and alarms (abnormal function). Using a combination of these logs, we can readily identify abnormal pump operation such as the development and progression of pump thrombosis, suction events and gastrointestinal bleeding. However, the research potential of log files was not discussed in these publications, particularly as it pertains to areas such as studying speed modulation and pulsatility in VADs.

Conclusions

VADs are an important staple in the treatment of patients with refractory HF. Log files provide a treasure-trove of information and knowledge that can be utilised for clinical benefit. Furthermore, log files provide an excellent tool for conducting research into device functionality. Current literature on the clinical utility of log files is sparse with much untapped potential.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Norton C, Georgiopoulou VV, Kalogeropoulos AP, Butler J. Epidemiology and Cost of Advanced Heart Failure. Prog Cardiovasc Dis. 2011;54:78–85.

    Article  Google Scholar 

  2. Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139:e56–e528.

    Article  Google Scholar 

  3. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Eng J Med. 2001;345:1435–43.

    Article  CAS  Google Scholar 

  4. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136:e137–61.

    Article  Google Scholar 

  5. Kadakia S, Moore R, Ambur V, Toyoda Y. Current status of the implantable LVAD. Gen Thorac Cardiovasc Surg. 2016;64:501–8.

    Article  Google Scholar 

  6. Lund LH, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report—2014; focus theme: retransplantation. J Heart Lung Transplant. 2014;33:996–1008.

    Article  Google Scholar 

  7. Mehra MR. Guidelines for Listing Candidates for Heart Transplant: A 10-Year Update. JAMA Cardiol. 2017;2:98–9.

    Article  Google Scholar 

  8. Lim HS, Howell N, Ranasinghe A. The physiology of continuous-flow left ventricular assist devices. J Card Fail. 2017;23:169–80.

    Article  Google Scholar 

  9. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Eng J Med. 2009;361:2241–51.

    Article  CAS  Google Scholar 

  10. Aaronson KD, Slaughter MS, Miller LW, et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125:3191–200.

    Article  Google Scholar 

  11. Rigatelli G, Santini F, Faggian G. Past and present of cardiocirculatory assist devices: a comprehensive critical review. J Geriatr Cardiol. 2012;9:389–400.

    PubMed  PubMed Central  Google Scholar 

  12. Rogers JG, Pagani FD, Tatooles AJ, et al. Intrapericardial left ventricular assist device for advanced heart failure. N Eng J Med. 2017;376:451–60.

    Article  Google Scholar 

  13. Kirklin JK, Pagani FD, Kormos RL, et al. Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. J Heart Lung Transplant. 2017;36:1080–6.

    Article  Google Scholar 

  14. Silva EJ. Mechanical circulatory support: current status and future directions. Prog Cardiovasc Dis. 2016;58:444–54.

    Article  Google Scholar 

  15. Consolo F, Esposti F, Gustar A, De Bonis M, Pappalardo F. Log files analysis and evaluation of circadian patterns for the early diagnosis of pump thrombosis with a centrifugal continuous-flow left ventricular assist device. J Heart Lung Transplant. 2019;38:1077–86.

    Article  Google Scholar 

  16. Jorde UP, Aaronson KD, Najjar SS, et al. Identification and management of pump thrombus in the heartware left ventricular assist device system: a novel approach using log file analysis. JACC: Heart Fail. 2015;3:849–56.

    Google Scholar 

  17. Rame JE, Birati EY. HeartWare left ventricular assist device pump thrombosis: a shift away from ramp. JACC Heart Fail. 2015;3:857–9.

    Article  Google Scholar 

  18. Chorpenning K, Brown MC, Voskoboynikov N, Reyes C, Dierlam AE, Tamez D. HeartWare controller logs a diagnostic tool and clinical management aid for the HVAD pump. ASAIO J. 2014;60:115–8.

    Article  Google Scholar 

  19. Slaughter MS, Ising MS, Tamez D, et al. Increase in circadian variation after continuous-flow ventricular assist device implantation. J Heart Lung Transplant. 2010;29:695–7.

    Article  Google Scholar 

  20. Suzuki K, Nishinaka T, Miyamoto T, Ichihara Y, Yamazaki K. Circadian variation of motor current observed in fixed rotation speed continuous-flow left ventricular assist device support. J Artif Organs. 2014;17:157–61.

    Article  Google Scholar 

  21. Hu SX, Keogh AM, Macdonald PS, et al. Interaction between physical activity and continuous-flow left ventricular assist device function in outpatients. J Card Fail. 2013;19:169–75.

    Article  CAS  Google Scholar 

  22. Muthiah K, Gupta S, Otton J, et al. Body position and activity, but not heart rate, affect pump flows in patients with continuous-flow left ventricular assist devices. JACC Heart Fail. 2014;2:323–30.

    Article  Google Scholar 

  23. Akin S, Soliman OI, Constantinescu AA, et al. Haemolysis as a first sign of thromboembolic event and acute pump thrombosis in patients with the continuous-flow left ventricular assist device HeartMate II. Neth Heart J. 2016;24:134–42.

    Article  CAS  Google Scholar 

  24. Dang G, Epperla N, Muppidi V, et al. Medical management of pump-related thrombosis in patients with continuous-flow left ventricular assist devices:a systematic review and meta-analysis. ASAIO J. 2017;63:373–85.

    Article  Google Scholar 

  25. Tchantchaleishvili V, Sagebin F, Ross RE, Hallinan W, Schwarz KQ, Massey HT. Evaluation and treatment of pump thrombosis and hemolysis. Ann Cardiothorac Surg. 2014;3:490–5.

    PubMed  PubMed Central  Google Scholar 

  26. Mehra MR, Salerno C, Naka Y, et al. A tale of the twist in the outflow graft: An analysis from the MOMENTUM 3 trial. J Heart Lung Transplant. 2018;37:1281–4.

    Article  Google Scholar 

  27. Duero Posada JG, Moayedi Y, Alhussein M, et al. Outflow graft occlusion of the HeartMate 3 left ventricular assist device. Circ Heart Fail. 2017;10:pii.e004275.

  28. Salerno CT, Sundareswaran KS, Schleeter TP, Moanie SL, Farrar DJ, Walsh MN. Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events. J Heart Lung Transplant. 2014;33:809–15.

    Article  Google Scholar 

  29. Tibrewala A, Nassif M, Raymer D, et al. Early elevated pump power and associated hemolysis amongst HeartMate II left ventricular assist devices. J Cardiac Fail. 2015;21:S39–40.

    Article  Google Scholar 

  30. Rich JD, Burkhoff D. HVAD flow waveform morphologies: theoretical foundation and implications for clinical practice. ASAIO J. 2017;63:526–35.

    Article  Google Scholar 

  31. Zimpfer D, Strueber M, Aigner P, et al. Evaluation of the HeartWare ventricular assist device Lavare cycle in a particle image velocimetry model and in clinical practice. Eur J Cardiothorac Surg. 2016;50:839–48.

    Article  Google Scholar 

  32. Investigators, A.S. Apogee, A HeartWare HVAD Destination Product Surveillance Registry (PSR) Platform. 2019; Available from: https://clinicaltrials.gov/ct2/show/NCT03697980.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiology Department, St Vincent’s Hospital, Sydney, Australia

    Sam Emmanuel & Christopher Simon Hayward

  2. School of Medicine, University of New South Wales, Sydney, Australia

    Sam Emmanuel, Jared Engelman & Christopher Simon Hayward

  3. School of Medicine, University of Notre Dame, Sydney, Australia

    Sam Emmanuel

  4. Victor Chang Cardiac Research Institute, Sydney, Australia

    Christopher Simon Hayward

Authors
  1. Sam Emmanuel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jared Engelman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christopher Simon Hayward
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher Simon Hayward.

Ethics declarations

CSH is a consultant for Medtronic and Abbott and has received research funds from Medtronic. Informed consent, an ethical statement and human/animal rights considerations were not applicable given this was a review article.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Emmanuel, S., Engelman, J. & Hayward, C.S. Reviewing the clinical utility of ventricular assist device log files. Indian J Thorac Cardiovasc Surg 36 (Suppl 2), 247–255 (2020). https://doi.org/10.1007/s12055-019-00891-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12055-019-00891-2

Keywords

Search

Navigation